[View in browser]( Proprietary Data Insights Financial Pros Top General Drug Manufacturer Stock Searches Last Month Rank Name Searches
#1 Palantir Technologies 677
#2 Longeveron Inc 613
#3 Shopify Inc 409
#4 Exela Technologies 318
#5 Sea Change Intl. 275 Sponsored [Learn the same techniques the pros use with this technical analysis guide.]( Technical analysis is one of two core analytical frameworks used by traders to predict the performance of commodities futures. By charting and evaluating peaks, bottoms, trends and various formations, traders can discern patterns and make buy and sell decisions based on this information. By reviewing our curated archive of technical analysis content, you can help ensure that you have the analytical tools necessary to trade with confidence. Whether youâre new to trading or just need a refresher course, this guide provides the ground-floor basics of technical analysis tools and techniques. With easy-to-understand explanations and clearly marked illustrations using real market charts, youâll want to refer to this guide again and again. Get Your Free Technical Guide Today! [Click here!]( Technology Defense + Tech = Investment? Defense + Tech = Investment? Parking your money in defense stocks isnât the worst idea when geopolitical tensions dominate the news headlines. And if that wasnât enough, inflation is running rampant at the grocery stores and gas pumps. On the other hand, you could invest in software companies that deliver high, scaleable margins. So combining the two should yield an amazing investment opportunity, right? Palantir could be considered a meme stock for all the fanfare it achieved when it debuted on the markets just a few short years ago. Heck, it still garners more looks by financial pros than Shopify (SHOP), arguably a much more valuable company. But that doesnât necessarily mean itâs a great investment. Worried about the market? CEO says this could be worth 35 Amazons (Sponsored) Amazonâs Jeff Bezos surprised investors recently when he revealed that one emerging technology is the key to Amazonâs future success... In fact, Bezos argues that âitâs hard to overstate the impactâ of this game-changing technology. The CEO of ARK Investments takes Bezos further: âWe think [it] could approach $17 trillion in market cap â which would be 35 Amazons.â What in the world could be worth 35 Amazons? [Find out in our new report]( Palantir Technologies (PLTR) Business Palantir builds software platforms for organizations that integrate their data, decisions, and operations. The companyâs technology is utilized in the intelligence community to assist in counterterrorism investigations and operations. Palantirâs platform breaks down into three categories: Gotham - Palantir Gotham is a commercially-available, AI-ready operating system that improves and accelerates decisions for operators across roles and all domains. Itâs used by government intelligence agencies, health organizations, armies, and police departments to fight terrorism, battle infectious diseases, win wars, and prevent civilian crime. Foundry - Foundry creates a central operating system for their data. This system is tailored for commercial organizations to collect, process, and analyze data in order to make better operational decisions efficiently. Apollo - A continuous delivery system that manages and deploys Palantir Gotham and Foundry. PLTR breaks its revenues down into two segments: Government and Commercial. PLTR technology can be applied for anti-money laundering, AI and machine learning, automotive and mobility, auto racing, contract management, cryptocurrency, data protection, defense, edge AI, energy, Federal Health, financial services, health and life sciences, intelligence, IoT analytics, retail, supply chain, and telecommunications. Some of the most recent announcements include partnering up with the CDC to bolster the fight against COVID-19. Financials PLTR has experienced significant growth over the last three years, reaching $1.5B in revenue in 2021, a near 50% spike from the 2020s $1B in revenue and 2019s 743M in revenue. Even more impressive is that the firm boosted its gross margin from 67.7% in 2020 to 78% in 2021. PLTR has a price to cash flow of 75.5x, which is rich when you consider the sector median is 20.39x. Furthermore, PLTR has a free cash flow of $321m. In other words, it has $321M of cash left over after it pays for its operating expenses and capital expenditures. PLTR has a free cash flow per share of 0.11x, which tells us it has $0.11 per share after paying for its operating and capital expenditures. PLTR has a current ratio of 4.34x. That means its assets are 4.34 times greater than its short-term liabilities. Moreover, PLTR has a quick ratio of 4.11x. That means its highly liquid assets are 4.11 times greater than its short-term liabilities. The firm has a reasonable debt-to-equity ratio of 0.10x. Valuation Valuation is concerning for PLTR. The firm trades at a price to sales ratio of 15.5x, significantly higher than the S&P 500 average of 2.9. The P/E (Non-GAAP) ratio for PLTR is 88.71x which is insane when considering the sector median is 19.27x. Despite the relatively high valuation, some investors are willing to be owners of the stock because of its growth potential. PLTR experienced revenue growth of 41.1% year over year which is nothing short of phenomenal. However, youâre paying a hefty premium for that growth. Our Opinion - 5/10 PLTR is a fast-growing software company that offers its customers a substantial amount of utility. However, valuations are sky-high, and the company is still not profitable. We like this company but still feel it's still priced high. We would be buyers at $8 per share. [We want to hear from you! Let us know your thoughts by clicking here]( #
[submit to reddit]( [submit to reddit]( [submit to reddit]( To ensure delivery of all emails, [allow us on your list](.
Update your email preferences or unsubscribe [here](.
View our privacy policy [here](#). Copyright ©2022 InvestingChannel. All rights reserved.
1325 Avenue of the Americas, Floor 27 & 28 New York, New York 10019 Disclaimer: This is not investment advice. This InvestingChannel, Inc. newsletter is for information purposes only and opinion-based. Futures, forex, stock, and options trading are not appropriate for all investors. There is a substantial risk of loss associated with trading these markets. Losses can and will occur. No system or methodology has ever been developed that can ensure returns or against losses. No representation or implication is being made that using any of these methodologies or systems will generate returns or ensure against losses. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions. [Link](